Back Pain

Ed Park, MD age-related-diseases, Podcasts 0 Comments

Recharge Biomedical Podcast 7 -Dr. Ed Park of Recharge Biomedical Clinic explains back pain and interviews three patients whose back pain disappeared while taking TA-65

Some quotes:
“If I could take just one supplement it would be TA-65 because it’s like the master. You know, if you can put the telomeres back on you know allow repair to happen.”
-Rocky C., a 60 yo chemical engineer.

” Boy it’s been fantastic! I don’t have to take any more anti-inflammatory drugs. I’ve noticed that I have increased flexibility and because of that, my attitude is a heck of a lot better. I’m looking forward to playing the best golf of my life. “- 65 yo Professional Golfer, Ray Carrasco

“For over 10 years I’ve been suffering with back pain. Now, I have none!”
Alem Melaku, 45 yo mother of twins

 

Ed Park, MD
Follow me

Ed Park, MD

I graduated from Harvard with honors in Biological Anthropology prior to earning my Medical Degree and Masters in Public Health from Columbia University.

In 2007, I became the nineteenth patient to sign up for the use of a herbally-extracted telomerase activator.

The results were so positive that I founded Recharge Biomedical Clinic in 2008 and have since become the leading medical expert in this exciting new field of regenerative medicine treating over 1,300 patients with this exciting new telomerase activation medicine.

I won two Houston Film Festival Awards for my screenplays about Hypatia of Alexandria and Ed Brown of Kentucky.

In 2010 I wrote and self-published a Sci-Fi Graphic Novel called MAXIMUM LIFESPAN

In 2013, I wrote and published "Telomere Timebombs; Defusing the Terror of Aging"

My websites are:
http://www.lokahi.guru (where you can learn about my RECHARGE adaptogenic supplement)
http://www.rechargebiomedical.com and
http://www.telomeretimebombs.com

You can sign up for my weekly blogs on this page and subscribe to my YouTube videos at https://www.youtube.com/drpark65
Ed Park, MD
Follow me

Latest posts by Ed Park, MD (see all)

Facebook Comments (0)

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *